11/19/2021 /
Vigabatrin (VGB) is the first-line treatment for infantile spasms (IS). Previous studies have shown that VGB exposure may cause vigabatrin-associated brain abnormalities on magnetic resonance imaging (MRI) (VABAM).
11/18/2021 /
Prior studies in the field of epilepsy surgical disparities have examined barriers in undergoing epilepsy surgical resections in disadvantaged populations involving trust in health providers, education level, social support, and fear of treatment.
11/18/2021 /
This month’s research news features two studies examining the underlying causes of epilepsy, and more.
11/17/2021 /
Hypertension may double an adult’s risk of developing epilepsy, according to a new study published in Epilepsia.
11/15/2021 /
Drug-resistant epilepsy (DRE) occurs at higher rates in children <3 years old. Epilepsy surgery is effective, but rarely utilized in young children despite developmental benefits of early seizure freedom.
11/12/2021 /
Recently, patient advocacy groups started using the name Gould syndrome to describe clinical features of COL4A1 and COL4A2 mutations. Among the chief concerns for caregivers of children with Gould syndrome are the challenges faced because of epilepsy, including severe manifestations such as infantile spasms.
11/12/2021 /
Researchers at the Kennedy Krieger Institute, with colleagues from Johns Hopkins University, have identified an important molecular mechanism that offers significant promise for understanding and developing novel treatment for drug-resistant seizures in newborns.
11/10/2021 /
A new study found patterns could be identified in patients who wear a special wristwatch monitoring device for six to 12 months, allowing about 30 minutes of warning before a seizure occurred.
11/09/2021 /
The analysis indicated that pathology and surgical location play critical roles in the outcome of epilepsy in children under the age of three.
